DNLI IPOs 16.0M* shares @$18.00: https://finance.yahoo.com/news/denali-therapeutics-announces-pricing-initial-000833887.html Denali is a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases.*Assuming exercise of underwriter’s option.